Epstein-Barr Virus (EBV) Prevalence and the Risk of Reactivation in Patients with Inflammatory Arthritis Using Anti-TNF Agents and in those who are Biologic Naive

OBJECTIVE: Anti-TNF agents (etanercept, infliximab and adalimumab) are widely used in inflammatory conditions, such as rheumatoid arthritis; however, they are not without side effects, potentially including lymphoma. We compared Epstein-Barr virus (EBV) levels in patients with inflammatory arthritis...

Descripción completa

Detalles Bibliográficos
Autores principales: McKeown, Emily, Pope, Janet E, Leaf, Suzanne
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714577/
https://www.ncbi.nlm.nih.gov/pubmed/19639039
http://dx.doi.org/10.2174/1874312900903010030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714577/
https://www.ncbi.nlm.nih.gov/pubmed/19639039
http://dx.doi.org/10.2174/1874312900903010030

Ejemplares similares